NDC 0641-6103-01 - ROBAXIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6103
- Requested NDC
- 0641-6103-01
- Package NDCs from labels
- 0641-6103-01, 0641-6103-10, 0641-6103-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ROBAXIN Injectable (methocarbamol injection, USP) | Hikma Pharmaceuticals USA Inc. | 2024-04-10 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6103-01 | ROBAXIN | 10 mL in 1 VIAL | INJECTION | 10 | 8 | |
| 0641-6103-10 | ROBAXIN | 10 in 1 CARTON | INJECTION | 10 | 8 | |
| 0641-6103-25 | ROBAXIN | 25 in 1 CARTON | INJECTION | 25 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6103-01 | ML - Milliliter | 0641-6103 | fea093a9-e51d-4877-9285-77155bc4380f | 1 | 2013-02-13 |
| 0641-6103-10 | ML - Milliliter | 0641-6103 | 86079302-612f-4f5d-8af4-0b2d1fa573d8 | 1 | 2024-03-12 |
| 0641-6103-25 | ML - Milliliter | 0641-6103 | e99128e7-032f-45f6-bb13-8e212a583b26 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METHOCARBAMOL | ACTIVE INGREDIENT | 125OD7737X | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| METHOCARBAMOL | ACTIVE MOIETY | 125OD7737X | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| POLYETHYLENE GLYCOL 300 | INACTIVE INGREDIENT | 5655G9Y8AQ | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medi-First First Aid Eye Wash | PURIFIED WATER | Unifirst First Aid Corporation | dcd7fe56-ff5c-4c8d-a415-6e363d7e53f4 | 2025-09-08 | Warnings | 059QF0KO0R |
| Green Guard First Aid Eye Wash | WATER | Unifirst First Aid Corporation | a4ba5526-b4e2-4bcc-9127-aa22ebf5017f | 2025-09-08 | Warnings | 059QF0KO0R |
| Medi-First Plus First Aid Eye Wash | WATER | Unifirst First Aid Corporation | d7ea80ca-b4a0-4476-8b50-b3425c6d456a | 2025-09-08 | Warnings | 059QF0KO0R |
| ECOLAB Eye Wash | PURIFIED WATER | ECOLAB Food Safety Specialties, Inc. | 4bcfa21a-791e-4d04-e054-00144ff88e88 | 2025-09-08 | Warnings | 059QF0KO0R |
| Physicians Care Eyewash | EYEWASH | Acme United Corporation | 3e239b12-9a75-339d-e063-6294a90a72ae | 2025-09-06 | Warnings | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL | Doc Rx | 5e55526f-bb34-4b67-85ea-b2765e8066bb | 2025-09-04 | Warnings, Adverse reactions | 125OD7737X |
| Sterile Water | WATER INJECTION | Henry Schein, Inc. | 3501952b-b556-4d5e-b81b-5c35ff87b475 | 2025-08-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL | PHOENIX RX LLC | 3b199152-bafc-e14a-e063-6394a90ab283 | 2025-07-29 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | f07c0a35-fb5d-43a1-a33e-d6a51a5fcd77 | 2025-07-23 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | 5f746f0f-e884-46d9-a104-529293b0fb90 | 2025-07-23 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | ff572473-90e3-4f3b-a40e-8b97b86d327b | 2025-07-16 | Warnings, Adverse reactions | 125OD7737X |
| Sterile Water | STERILE WATER | Nephron Pharmaceuticals Corporation | bc04a883-babc-87a6-e053-2995a90a3dfd | 2025-07-11 | Warnings, Adverse reactions | 059QF0KO0R |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6500c6eb-fa1e-46a5-839f-13047e107e97 | 2025-07-08 | Warnings, Adverse reactions | 125OD7737X |
| Plaque identifying | PLAQUE IDENTIFYING | Shenzhen Yagao Technology Co., Ltd. | 37eeb656-22f1-7372-e063-6394a90ad041 | 2025-06-19 | Warnings | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | fe872a3a-fb14-4a0a-b9e4-c9f1885b4978 | 2025-06-18 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | Granulation Technology, Inc. | 70c5342c-9597-4fe6-863c-f8ae4adc063a | 2025-06-10 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Golden State Medical Supply, Inc. | c67d3e2b-92cd-1b97-e053-2a95a90af36f | 2025-06-10 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | 9357672f-5d4d-40f5-a304-e0c34e174dc3 | 2025-06-09 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 43ea5baa-4200-47ff-8819-44c802cba977 | 2025-06-02 | Warnings, Adverse reactions | 125OD7737X |
| METHOCARBAMOL | METHOCARBAMOL | Preferred Pharmaceuticals Inc. | 5a48be27-5069-40f3-85de-86f248ae232f | 2025-06-02 | Warnings, Adverse reactions | 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.